Net Medical Xpress Solutions, Inc. (NMXS)
USD 0.01
(25.0%)
USD 0.01
(25.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 597 Thousand USD | -88.54% |
| 2022 | 5.21 Million USD | 194.74% |
| 2021 | 1.76 Million USD | 58.14% |
| 2020 | 1.11 Million USD | -32.2% |
| 2019 | 1.64 Million USD | -21.51% |
| 2018 | 2.1 Million USD | -25.65% |
| 2017 | 2.82 Million USD | -7.19% |
| 2016 | 3.04 Million USD | -27.88% |
| 2015 | 4.22 Million USD | -7.88% |
| 2014 | 4.58 Million USD | -4.74% |
| 2013 | 4.81 Million USD | 23.2% |
| 2012 | 3.9 Million USD | 21.76% |
| 2011 | 3.2 Million USD | -7.98% |
| 2010 | 3.48 Million USD | -4.78% |
| 2009 | 3.66 Million USD | 123.72% |
| 2008 | 1.63 Million USD | 65.59% |
| 2007 | 988 Thousand USD | 8.21% |
| 2006 | 913 Thousand USD | -34.74% |
| 2005 | 1.39 Million USD | 37.43% |
| 2004 | 1.01 Million USD | -21.69% |
| 2003 | 1.3 Million USD | -21.59% |
| 2002 | 1.65 Million USD | 29.63% |
| 2001 | 1.27 Million USD | 69.18% |
| 2000 | 756 Thousand USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 3000.00 USD | -95.31% |
| 2023 Q2 | 160 Thousand USD | -29.2% |
| 2023 Q1 | 226 Thousand USD | -69.17% |
| 2023 FY | 597 Thousand USD | -88.54% |
| 2023 Q4 | 64 Thousand USD | -56.46% |
| 2023 Q3 | 147 Thousand USD | -8.13% |
| 2022 Q2 | 1.5 Million USD | -21.19% |
| 2022 FY | 5.21 Million USD | 194.74% |
| 2022 Q3 | 1 Million USD | -32.93% |
| 2022 Q1 | 1.9 Million USD | 132.28% |
| 2022 Q4 | 733 Thousand USD | -27.28% |
| 2021 Q4 | 821 Thousand USD | 140.76% |
| 2021 Q1 | 290 Thousand USD | 0.0% |
| 2021 Q2 | 315 Thousand USD | 8.62% |
| 2021 FY | 1.76 Million USD | 58.14% |
| 2021 Q3 | 341 Thousand USD | 8.25% |
| 2020 FY | 1.11 Million USD | -32.2% |
| 2019 FY | 1.64 Million USD | -21.51% |
| 2018 Q2 | 546 Thousand USD | 10.53% |
| 2018 FY | 2.1 Million USD | -25.65% |
| 2018 Q1 | 494 Thousand USD | 0.0% |
| 2017 Q3 | 628 Thousand USD | -5.71% |
| 2017 FY | 2.82 Million USD | -7.19% |
| 2017 Q2 | 666 Thousand USD | -8.89% |
| 2017 Q1 | 731 Thousand USD | 12.63% |
| 2016 Q3 | 651 Thousand USD | -21.28% |
| 2016 Q1 | 918 Thousand USD | 8.9% |
| 2016 Q4 | 649 Thousand USD | -0.31% |
| 2016 Q2 | 827 Thousand USD | -9.91% |
| 2016 FY | 3.04 Million USD | -27.88% |
| 2015 Q4 | 843 Thousand USD | -16.53% |
| 2015 Q3 | 1.01 Million USD | -10.46% |
| 2015 FY | 4.22 Million USD | -7.88% |
| 2015 Q2 | 1.12 Million USD | -9.03% |
| 2015 Q1 | 1.24 Million USD | 18.43% |
| 2014 FY | 4.58 Million USD | -4.74% |
| 2014 Q2 | 1.17 Million USD | -7.63% |
| 2014 Q1 | 1.27 Million USD | 10.04% |
| 2014 Q4 | 1.04 Million USD | -4.03% |
| 2014 Q3 | 1.09 Million USD | -7.07% |
| 2013 Q1 | 1.22 Million USD | 15.41% |
| 2013 Q2 | 1.2 Million USD | -1.23% |
| 2013 FY | 4.81 Million USD | 23.2% |
| 2013 Q4 | 1.15 Million USD | -6.02% |
| 2013 Q3 | 1.22 Million USD | 1.91% |
| 2012 Q2 | 960 Thousand USD | 4.01% |
| 2012 Q1 | 923 Thousand USD | 16.39% |
| 2012 FY | 3.9 Million USD | 21.76% |
| 2012 Q4 | 1.05 Million USD | 9.75% |
| 2012 Q3 | 964 Thousand USD | 0.42% |
| 2011 Q3 | 719 Thousand USD | -5.15% |
| 2011 Q2 | 758 Thousand USD | -19.02% |
| 2011 Q1 | 936 Thousand USD | 5.29% |
| 2011 FY | 3.2 Million USD | -7.98% |
| 2011 Q4 | 793 Thousand USD | 10.29% |
| 2010 Q2 | 780 Thousand USD | -13.62% |
| 2010 Q4 | 889 Thousand USD | -2.63% |
| 2010 Q3 | 913 Thousand USD | 17.05% |
| 2010 Q1 | 903 Thousand USD | -2.27% |
| 2010 FY | 3.48 Million USD | -4.78% |
| 2009 Q3 | 912 Thousand USD | 1.11% |
| 2009 FY | 3.66 Million USD | 123.72% |
| 2009 Q2 | 902 Thousand USD | -1.42% |
| 2009 Q4 | 924 Thousand USD | 1.32% |
| 2009 Q1 | 915 Thousand USD | 34.76% |
| 2008 FY | 1.63 Million USD | 65.59% |
| 2008 Q3 | 520 Thousand USD | 157.43% |
| 2008 Q2 | 202 Thousand USD | -14.04% |
| 2008 Q1 | 235 Thousand USD | -5.24% |
| 2008 Q4 | 679 Thousand USD | 30.58% |
| 2007 FY | 988 Thousand USD | 8.21% |
| 2007 Q4 | 248 Thousand USD | 6.44% |
| 2007 Q3 | 233 Thousand USD | -12.73% |
| 2007 Q2 | 267 Thousand USD | 11.25% |
| 2007 Q1 | 240 Thousand USD | -10.78% |
| 2006 Q1 | 199 Thousand USD | 59.2% |
| 2006 FY | 913 Thousand USD | -34.74% |
| 2006 Q4 | 269 Thousand USD | 35.18% |
| 2006 Q3 | 199 Thousand USD | -19.11% |
| 2006 Q2 | 246 Thousand USD | 23.62% |
| 2005 Q3 | 640 Thousand USD | 276.47% |
| 2005 Q4 | 125 Thousand USD | -80.47% |
| 2005 Q2 | 170 Thousand USD | -63.36% |
| 2005 Q1 | 464 Thousand USD | 1306.06% |
| 2005 FY | 1.39 Million USD | 37.43% |
| 2004 FY | 1.01 Million USD | -21.69% |
| 2004 Q2 | 409 Thousand USD | 11.44% |
| 2004 Q3 | 208 Thousand USD | -49.14% |
| 2004 Q4 | 33 Thousand USD | -84.13% |
| 2004 Q1 | 367 Thousand USD | 23.99% |
| 2003 Q2 | 197 Thousand USD | -54.19% |
| 2003 Q1 | 430 Thousand USD | 152.94% |
| 2003 Q3 | 377 Thousand USD | 91.37% |
| 2003 FY | 1.3 Million USD | -21.59% |
| 2003 Q4 | 296 Thousand USD | -21.49% |
| 2002 Q3 | 212 Thousand USD | -71.88% |
| 2002 Q1 | 522 Thousand USD | 85.77% |
| 2002 FY | 1.65 Million USD | 29.63% |
| 2002 Q4 | 170 Thousand USD | -19.81% |
| 2002 Q2 | 754 Thousand USD | 44.44% |
| 2001 Q3 | 407 Thousand USD | 28.8% |
| 2001 Q4 | 281 Thousand USD | -30.96% |
| 2001 FY | 1.27 Million USD | 69.18% |
| 2001 Q1 | 275 Thousand USD | 0.0% |
| 2001 Q2 | 316 Thousand USD | 14.91% |
| 2000 FY | 756 Thousand USD | 0.0% |
| 2000 Q1 | 104 Thousand USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Achiko AG | 62.5 Thousand USD | -855.093% |
| Accelera Innovations, Inc | - USD | -Infinity% |
| Aspyra Inc. | 8.52 Million USD | 92.998% |
| Cannabis Sativa, Inc. | 1.17 Million USD | 49.141% |
| CompuMed, Inc. | 5.83 Million USD | 89.774% |
| CompuGroup Medical SE & Co. KGaA | 1.31 Billion USD | 99.954% |
| Cogstate Limited | 43.42 Million USD | 98.625% |
| CareView Communications, Inc. | 9.68 Million USD | 93.836% |
| Craneware plc | 189.26 Million USD | 99.685% |
| Caduceus Software Systems Corp. | 6.58 Million USD | 90.939% |
| Certive Solutions Inc. | 1.27 Million USD | 53.006% |
| Drug Free Solution, Inc. | 805.00 USD | -74061.491% |
| DATATRAK International, Inc. | 6.18 Million USD | 90.346% |
| Strainsforpains, Inc. | 84.11 Thousand USD | -609.734% |
| Healixa Inc. | 598.88 Thousand USD | 0.315% |
| Easy Technologies Inc. | - USD | -Infinity% |
| eWellness Healthcare Corporation | - USD | -Infinity% |
| Founders Bay Holdings | 16.45 Million USD | 96.373% |
| Health Discovery Corporation | - USD | -Infinity% |
| Healthcare Integrated Technologies, Inc. | 322 Thousand USD | -85.404% |
| H-Source Holdings Ltd. | - USD | -Infinity% |
| InterCare DX, Inc. | - USD | -Infinity% |
| IQ-AI Limited | 775.75 Thousand USD | 23.043% |
| Cannabiz Mobile, Inc. | - USD | -Infinity% |
| Mednow Inc. | 12.99 Million USD | 95.406% |
| Galileo Life Sciences, Inc. | - USD | -Infinity% |
| MediXall Group, Inc. | 59.26 Thousand USD | -907.289% |
| Mitesco, Inc. | - USD | -Infinity% |
| MobileSmith, Inc. | 1.57 Million USD | 62.044% |
| NantHealth, Inc. | 67 Million USD | 99.109% |
| OneLife Technologies Corp. | - USD | -Infinity% |
| ORHub, Inc. | 324.86 Thousand USD | -83.766% |
| Patient Access Solutions, Inc. | 212.73 Thousand USD | -180.63% |
| Pharma-Bio Serv, Inc. | 16.97 Million USD | 96.483% |
| PPJ Healthcare Enterprises, Inc. | 711.03 Thousand USD | 16.038% |
| Medical Cannabis Payment Solutions, Inc. | - USD | -Infinity% |
| Renalytix Plc | 2.28 Million USD | 73.919% |
| Revium Recovery Inc. | - USD | -Infinity% |
| RYAH Group, Inc. | - USD | -Infinity% |
| Carepay Inc. | 1.46 Million USD | 59.231% |
| Vaso Corporation | 81.02 Million USD | 99.263% |
| Vynleads, Inc. | - USD | -Infinity% |